Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

TG Therapeutics Raises FY2025 Sales Guidance from $585.000M to $600.000M vs $588.045M Est

Author: Benzinga Newsdesk | November 03, 2025 07:03am

TG Therapeutics (NASDAQ:TGTX) raises FY2025 sales outlook from $585.000 million to $600.000 million vs $588.045 million estimate.

Posted In: TGTX